(Q35804343)

10 August 2017

1 reference

title

Systemic hemodynamic abnormalities and vasopressor therapy in sepsis and septic shock (English)

1 reference

10 August 2017

0 references

1 reference

1

Quezado ZM

1 reference

10 August 2017

Z. M. Quezado

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1519602

4 October 2022

C. Natanson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1519602

4 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1519602

4 October 2022

publication date

1 September 1992

1 reference

American Journal of Kidney Diseases

10 August 2017

published in

1 reference

10 August 2017

volume

20

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

214-222

1 reference

Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Profound but reversible myocardial depression in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Serial cardiovascular variables in survivors and nonsurvivors of human septic shock: heart rate as an early predictor of prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Septic shock: the cardiovascular abnormality and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Depressed left ventricular performance. Response to volume infusion in patients with sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Endotoxemia in human septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

The cardiovascular response of normal humans to the administration of endotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Cachectin and tumour necrosis factor as two sides of the same biological coin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Detection of circulating tumor necrosis factor after endotoxin administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

TNF but not IL-1 in dogs causes lethal lung injury and multiple organ dysfunction similar to human sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

A circulating myocardial depressant substance is associated with cardiac dysfunction and peripheral hypoperfusion (lactic acidemia) in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Ibuprofen in canine endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

On-site physician staffing in a community hospital intensive care unit. Impact on test and procedure use and on patient outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Renal effects of norepinephrine used to treat septic shock patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Norepinephrine alone versus norepinephrine plus low-dose dopamine: enhanced renal blood flow with combination pressor therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

Experience with phenylephrine as a component of the pharmacologic support of septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980693-7

7 January 2021

10.1016/S0272-6386(12)80693-7

Identifiers

DOI

1 reference

10 August 2017

1 reference